Showing results (1501-1510 of 2,575) with videos related to

Sort By:
Pageof 258
Plos One|December 16, 2014
The Pseudomonas syringae type III effector HopF2 suppresses Arabidopsis stomatal immunityBrenden Hurley, Donghyuk Lee, Adam Mott, et al.
Pediatric Neurology|March 22, 2016
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated EncephalomyelitisCynthia Beatty, Rachael A Bowler, Osman Farooq, et al.
AJNR. American Journal of Neuroradiology|November 25, 2017
Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MSR Zivadinov, N Bergsland, J R Korn, et al.
Scientific Reports|April 29, 2021
Evaluation of digital dispense-assisted broth microdilution antimicrobial susceptibility testing for Pseudomonas aeruginosa isolatesShawn T Clark, Patrick J Stapleton, Pauline W Wang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Disorder with consequence: Phosphorylation sites in HSPB5 yield distinct structural outcomesNatalie L Stone, Maria K Janowska, Lucas Narisawa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2023
Predicting employment deterioration with the Processing Speed Test (PST) and SDMT in multiple sclerosisMichael G Jaworski, John K Gillies, Margaret Youngs, et al.
Lancet (London, England)|December 12, 2022
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b studyEmma Guttman-Yassky, Eric L Simpson, Kristian Reich, et al.
Multiple Sclerosis and Related Disorders|June 7, 2022
Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosisDejan Jakimovski, Robert Zivadinov, Laura Pelizzari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 18, 2025
Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE studyRobert J Fox, Stanley Cohan, Yang Mao-Draayer, et al.
Breast Cancer Research and Treatment|November 1, 2005
N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinomaChandandeep Nagi, Mitchell Guttman, Shabnam Jaffer, et al.
Pageof 258